查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827806

2025年全球DNA與基因晶片市場報告

DNA And Gene Chip Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，DNA和基因晶片市場快速擴張，市場規模從2024年的81.9億美元成長到2025年的92億美元，複合年成長率為12.2%。預測期內的成長主要得益於基因組學研究的進步、個人化醫療的興起、人類基因組計劃的里程碑、藥物研發以及疾病生物標記的識別。

預計未來幾年，DNA和基因晶片市場規模將快速成長，到2029年將達到151.3億美元，複合年成長率為13.3%。預測期內的成長可歸因於精準醫療的進步、生物標記發現的不斷擴展、個人化醫療的發展、癌症研究的應用以及研究經費的增加。預測期內的主要趨勢包括技術進步、產品創新、法律規範和合規性、對罕見疾病的關注以及成本的持續降低。

DNA和基因晶片是一種微晶片，其特徵是將微小的DNA探針附著在固體表面上，可以識別測試樣本中的DNA，構成DNA雙螺旋的一半。如果測試樣本中的DNA發生突變，則該DNA將無法正確與晶片上的序列結合。這項技術用於測量基因表現水平，並確定一個人的DNA是否發生突變。

DNA或基因晶片的主要類型包括寡核苷酸DNA（O-DNA）、互補DNA（C-DNA）和其他變異。寡核苷酸DNA由3-20個核苷酸的短單鏈股或雙鏈DNA或RNA片段組成。與此技術相關的產品包括耗材和儀器，其應用範圍涵蓋癌症診斷、基因表現、蛋白質體學、基因組學、藥物研發和農業基因組學。相關的最終用戶產業多種多樣，包括學術和政府研究機構、生物技術和製藥公司、醫院以及診斷中心。

2025年春季，美國關稅上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快研發更具成本效益的材料來降低風險。

本研究報告是商業研究公司（The Business Research Company）新報告系列的一部分，該系列提供DNA和基因晶片市場統計數據，包括全球市場規模、各地區市場佔有率、各競爭對手的市場佔有率、詳細的DNA和基因晶片細分市場、市場趨勢和商業機會，以及您在DNA和基因晶片行業取得成功所需的數據。這份DNA和基因晶片市場研究報告透過對產業現狀和未來狀況的詳細分析，為您提供全面的觀點。

未來五年的預測成長率為13.3%，較我們先前對該市場的預測略有下降0.2%。下降主要源自於美國與其他國家之間關稅的影響。美國可能會直接感受到這種影響，即對來自瑞典和奧地利等主要地區的寡核苷酸探針和微陣列玻璃基板徵收關稅，這可能導致基因檢測結果延遲，並增加個人化醫療應用的成本。此外，這種影響可能會透過互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易造成的負面影響，在更廣泛的範圍內顯現。

DNA和基因晶片市場正在經歷顯著成長，這主要得益於對早期癌症檢測需求的不斷成長。隨著癌症成為普遍的健康問題，人們迫切需要能夠及時識別的技術。 DNA和基因晶片在測量基因表現、了解遺傳圖譜以及評估癌細胞中的基因組調控元件方面發揮著至關重要的作用。美國癌症協會估計，2022年美國將新增190萬例癌症病例，並有609,360例癌症死亡病例，凸顯了DNA和基因晶片在推進早期癌症檢測方面將發揮的重要作用。

人們對個人化醫療日益成長的興趣預計將推動未來 DNA 和基因晶片市場的擴張。個人化醫療是一種新的醫療保健方法，它利用個人的基因圖譜來指導疾病預防、診斷和治療方面的決策。 DNA 和基因晶片在個人化醫療中發揮關鍵作用，它透過分析個人的基因圖譜來識別潛在的疾病風險和治療方案。例如，美國健康報導機構STAT 報導，2022 年 10 月將有超過 75,000 種基因檢測產品和 300 多種個人化藥物可供選擇。因此，人們對個人化醫療日益成長的興趣正在推動 DNA 和基因晶片市場的成長。

策略夥伴關係與合作已成為DNA與基因晶片市場的主要趨勢。許多該領域的公司正在尋求聯盟，以鞏固其在DNA和基因晶片市場的地位。例如，2022年6月，總部位於印度的綜合系統生物學平台公司Avesthagen Limited與總部位於印度的資訊科技公司Wipro Limited建立了為期四年的策略夥伴關係關係。這項合作關係涉及實施計劃，並專注於基因組定序服務。此外，2022年5月，美國分析設備供應商賽默飛世爾科技與卡達基金會（QF）旗下的卡達基因組計畫（QGP）合作，利用19個阿拉伯國家的全基因組定序數據，為泛阿拉伯族群開發客製化的Axiom基因型鑒定陣列。該晶片包含80萬個基因變異，旨在加強糖尿病、心血管疾病、自閉症和癌症等疾病的基因組研究。此次合作支持卡達改善公民健康、推動全球阿拉伯人民精準醫療的國家願景，並藉助賽默飛世爾的Axiom晶片技術加速精準醫療舉措。

DNA 和基因晶片市場的關鍵參與者正在開發創新的基因型鑒定晶片，例如 Axiom YNS_Mol1，以推動食品工業的發展並促進昆蟲消費。 Axiom YNS_Mol1 是一種專為昆蟲育種而設計的基因型鑒定晶片，特別是針對穀蟲。例如，2023 年 6 月，專門從事昆蟲生產的法國公司 Ynsect 推出了世界上第一個用於昆蟲育種的基因型鑒定晶片 Axiom YNS_Mol1。這款開創性的晶片是與賽默飛世爾科技合作開發的，旨在改變昆蟲育種以實現永續的食品和寵物食品生產。此晶片分析遺傳性狀，增加基因組多樣性並改善穀蟲的性狀，包括生長、繁殖和抗病性。這項創新舉措是 Ynsect 的 YnFABRE計劃的一部分，有助於發展昆蟲養殖和應對環境挑戰的永續解決方案。

2022年12月，總部位於德國、提供DNA和基因晶片的科技公司默克集團與Synplogen簽署了一份合作備忘錄。此次夥伴關係旨在推進日本基於病毒載體的基因療法的開發、生產和測試。此外，默克將在其位於東京的M Lab合作中心為Synplogen的科學家提供實務培訓，以促進知識轉移和技術援助。 Synplogen株式會社是一家專注於DNA合成的日本公司。

DNA和基因晶片市場包括設備和耗材的銷售。該市場的價值是指“出廠價”，即商品製造商或創造者出售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接出售給最終客戶的價值。該市場中的商品價值還包括商品創造者出售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球DNA與基因晶片：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球DNA與基因晶片市場：成長率分析
  • 全球 DNA 與基因晶片市場表現：規模與成長，2019-2024 年
  • 全球 DNA 與基因晶片市場預測：規模與成長，2024-2029 年，2034 年
  • 全球 DNA 和基因晶片：總目標市場 (TAM)

第6章 市場細分

  • 全球 DNA 和基因晶片市場：按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 寡核苷酸DNA（o-DNA）
  • 互補DNA（c-DNA）
  • 其他類型
  • 全球 DNA 和基因晶片市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 癌症診斷
  • 基因表現
  • 蛋白質體學
  • 基因組學
  • 藥物研發
  • 農業基因組學
  • 其他用途
  • 全球 DNA 和基因晶片市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 學術和政府研究組織
  • 生物技術和製藥公司
  • 醫院和診斷中心
  • 其他最終用戶
  • 全球 DNA 和基因晶片市場：按寡核苷酸 DNA (o-DNA) 細分，類型，實際情況和預測，2019-2024 年，2024-2029 年，2034 年
  • 客製化寡核苷酸晶片
  • 市售寡核苷酸陣列
  • 全球 DNA 和基因晶片市場：按互補 DNA (c-DNA) 細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • cDNA微陣列
  • cDNA表現陣列
  • 全球 DNA 和基因晶片市場：按類型、實際和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 單細胞RNA定序晶片
  • SNP（單核苷酸多態性）晶片
  • 全基因組擴增晶片

第7章 區域和國家分析

  • 全球 DNA 和基因晶片市場：區域表現和預測（2019-2024 年、2024-2029 年、2034 年）
  • 全球 DNA 和基因晶片市場：按國家/地區分類、實際規模和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • DNA與基因晶片市場：競爭格局
  • DNA與基因晶片市場：公司簡介
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Macrogen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Greiner Bio-One International GmbH
  • CapitalBio Corporation
  • Microarrays Inc.
  • bioMerieux SA
  • Applied Microarrays Inc.
  • Biometrix Technology Inc.
  • Oxford Gene Technology IP Limited
  • Bioneer Corporation
  • Eurofins MWG Operon LLC
  • F. Hoffmann-La Roche Ltd
  • QIAGEN NV
  • Bio-Rad Laboratories Inc.
  • BioChain Institute Inc.
  • Cepheid
  • Eppendorf AG

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年 DNA 與基因晶片市場：提供新機會的國家
  • 2029 年 DNA 與基因晶片市場：細分市場將帶來新機會
  • 2029 年 DNA 與基因晶片市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r22546u

A DNA and gene chip is a microchip featuring microscopic DNA probes attached to a solid surface, capable of identifying DNA from test samples and constituting one half of the DNA double helix. When the test sample of DNA carries a mutation, the DNA fails to bind properly to the sequence on the chip. This technology is employed to measure the expression levels of genes or determine whether a person's DNA exhibits mutations, variations in DNA that can lead to diseases.

The main types of DNA and gene chips include oligonucleotide DNA (O-DNA), complementary DNA (C-DNA), and other variations. Oligonucleotide DNA comprises short single- or double-stranded DNA or RNA fragments with three to twenty nucleotides. Products associated with this technology include consumables and instruments, with applications ranging from cancer diagnostics, gene expression, proteomics, genomics, drug discovery, to agrigenomics. End-user industries involved encompass academic and government research institutes, biotechnology and pharmaceutical companies, hospitals and diagnostics centers, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The DNA and gene chips market research report is one of a series of new reports from The Business Research Company that provides DNA and gene chips market statistics, including DNA and gene chips industry global market size, regional shares, competitors with a DNA and gene chips market share, detailed DNA and gene chips market segments, market trends and opportunities, and any further data you may need to thrive in the DNA and gene chips industry. This DNA and gene chips market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dna and gene chip market size has grown rapidly in recent years. It will grow from $8.19 billion in 2024 to $9.2 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to genomic research advancements, rise of personalized medicine, human genome project milestones, drug discovery and development, disease biomarker identification.

The dna and gene chip market size is expected to see rapid growth in the next few years. It will grow to $15.13 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to advancements in precision medicine, expansion of biomarker discovery, growth of personalized therapeutics, application in cancer research, increasing research funding. Major trends in the forecast period include technological advancements, product innovations, regulatory framework and compliance, focus on rare diseases, continuous reduction in costs.

The forecast of 13.3% growth over the next five years indicates a slight reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on oligonucleotide probes and microarray glass substrates, sourced from key regions such as Sweden and Austria, which could lead to delayed genetic testing results and increased costs for personalized medicine applications.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The DNA and gene chip market is experiencing substantial growth, primarily fueled by the escalating demand for early cancer detection. Cancer, a pervasive health concern, prompts an urgent need for technologies facilitating timely identification. DNA and gene chips play a pivotal role in measuring gene expression, understanding genetic landscapes, and assessing genomic regulatory elements in cancer cells. Notably, the American Cancer Society estimates approximately 1.9 million new cancer cases and 609,360 deaths in the United States for 2022, emphasizing the critical role of DNA and gene chips in advancing early cancer detection.

The growing emphasis on personalized medicine is anticipated to drive the expansion of the DNA and gene chip market in the future. Personalized medicine is an emerging approach in healthcare that utilizes an individual's genetic profile to inform decisions regarding disease prevention, diagnosis, and treatment. DNA and gene chips play a crucial role in personalized medicine by analyzing a person's genetic profile to identify potential disease risks and treatment options. For example, in October 2022, reports from STAT, a US-based health-focused news organization, indicated that there were over 75,000 genetic testing products and 300 personalized medicines available. Consequently, the heightened focus on personalized medicine is fueling the growth of the DNA and gene chip market.

Strategic partnerships and collaborations are emerging as significant trends in the DNA and gene chip market. Many companies in this field are seeking alliances to enhance their positions within the DNA and gene chip market. For example, in June 2022, Avesthagen Limited, an India-based integrated systems biology platform company, established a four-year strategic partnership with Wipro Limited, an India-based information technology firm. This collaboration involves executing the project titled "Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA for lung cancer," which focuses on genomics sequencing services. Additionally, in May 2022, Thermo Fisher Scientific, a US-based supplier of analytical instruments, partnered with the Qatar Genome Program (QGP), part of the Qatar Foundation (QF), to develop a custom Axiom genotyping array for pan-Arab populations using whole genome sequencing data from 19 Arab countries. This array, featuring 800,000 variants, aims to enhance genomic research on conditions such as diabetes, cardiovascular diseases, autism, and cancer. The collaboration supports Qatar's national vision for improved population health and the advancement of precision medicine for Arab individuals globally, facilitated by Thermo Fisher's Axiom microarray technology, which accelerates precision medicine initiatives.

Key players in the DNA and gene chip market are developing innovative genotyping chips, such as the Axiom YNS_Mol1, to advance the food industry and promote insect consumption. The Axiom YNS_Mol1 is a genotyping chip specifically designed for insect breeding, particularly for the Tenebrio Molitor mealworm. For instance, in June 2023, Ynsect, a France-based company specializing in insect production, introduced the world's first genotyping chip for insect breeding, the Axiom YNS_Mol1. Developed in collaboration with Thermo Fisher Scientific, this pioneering chip aims to transform insect breeding for sustainable food and pet food production. It analyzes genetic traits to enhance genomic diversity and improve characteristics such as growth, reproduction, and disease resistance in Tenebrio Molitor mealworms. This innovative initiative is part of Ynsect's YnFABRE project, contributing to the advancement of entomoculture and sustainable solutions in addressing environmental challenges.

In December 2022, The Merck Group, a German-based science and technology company that offers DNA and gene chips, signed a Memorandum of Understanding (MoU) with Synplogen. This partnership aims to advance the development, manufacturing, and testing of viral vector-based gene therapies in Japan. Additionally, Merck will provide practical training for Synplogen's scientists at its M Lab Collaboration Center in Tokyo, facilitating knowledge transfer and technical assistance. Synplogen Co. Ltd. is a Japan-based company specializing in DNA synthesis.

Major companies operating in the DNA and gene chip market are PerkinElmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies Inc., Greiner Bio-One International GmbH, CapitalBio Corporation, Microarrays Inc., bioMerieux SA, Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, Eurofins MWG Operon LLC, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Cepheid, Eppendorf AG, Fluidigm Corporation, GE Healthcare, Genisphere LLC, Gyros Protein Technologies AB, Hitachi High-Technologies Corporation, LC Sciences

North America was the largest region in the DNA and gene chip market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna and gene chip market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dna and gene chip market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The DNA and gene chip market consists of sales of instrumentation and consumables. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA And Gene Chip Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dna and gene chip market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dna and gene chip ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dna and gene chip market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Oligonucleotide DNA (o-DNA); Complementary DNA (c-DNA); Other Types
  • 2) By Application: Cancer Diagnostics; Gene Expression; Proteomics; Genomics; Drug Discovery; Agrigenomics; Other Applications
  • 3) By End User: Academic And Government Research Institutes; Biotechnology And Pharmaceutical Companies; Hospitals And Diagnostics Centers; Other End Users
  • Subsegments:
  • 1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips; Commercial Oligonucleotide Arrays
  • 2) By Complementary DNA (c-DNA): cDNA Microarrays; cDNA Expression Arrays
  • 3) By Other Types: Single-Cell RNA Sequencing Chips; SNP (Single Nucleotide Polymorphism) Chips; Whole Genome Amplification Chips
  • Companies Mentioned: PerkinElmer Inc.; Illumina Inc.; Thermo Fisher Scientific Inc.; Macrogen Inc.; Agilent Technologies Inc.; Greiner Bio-One International GmbH; CapitalBio Corporation; Microarrays Inc.; bioMerieux SA; Applied Microarrays Inc.; Biometrix Technology Inc.; Oxford Gene Technology IP Limited; Bioneer Corporation; Eurofins MWG Operon LLC; F. Hoffmann-La Roche Ltd; QIAGEN N.V.; Bio-Rad Laboratories Inc.; BioChain Institute Inc.; Cepheid; Eppendorf AG; Fluidigm Corporation; GE Healthcare; Genisphere LLC; Gyros Protein Technologies AB; Hitachi High-Technologies Corporation; LC Sciences
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. DNA And Gene Chip Market Characteristics

3. DNA And Gene Chip Market Trends And Strategies

4. DNA And Gene Chip Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global DNA And Gene Chip Growth Analysis And Strategic Analysis Framework

  • 5.1. Global DNA And Gene Chip PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global DNA And Gene Chip Market Growth Rate Analysis
  • 5.4. Global DNA And Gene Chip Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global DNA And Gene Chip Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global DNA And Gene Chip Total Addressable Market (TAM)

6. DNA And Gene Chip Market Segmentation

  • 6.1. Global DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oligonucleotide DNA (o-DNA)
  • Complementary DNA (c-DNA)
  • Other Types
  • 6.2. Global DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Diagnostics
  • Gene Expression
  • Proteomics
  • Genomics
  • Drug Discovery
  • Agrigenomics
  • Other Applications
  • 6.3. Global DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Government Research Institutes
  • Biotechnology And Pharmaceutical Companies
  • Hospitals And Diagnostics Centers
  • Other End Users
  • 6.4. Global DNA And Gene Chip Market, Sub-Segmentation Of Oligonucleotide DNA (o-DNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Custom Oligonucleotide Chips
  • Commercial Oligonucleotide Arrays
  • 6.5. Global DNA And Gene Chip Market, Sub-Segmentation Of Complementary DNA (c-DNA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • cDNA Microarrays
  • cDNA Expression Arrays
  • 6.6. Global DNA And Gene Chip Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Cell RNA Sequencing Chips
  • SNP (Single Nucleotide Polymorphism) Chips
  • Whole Genome Amplification Chips

7. DNA And Gene Chip Market Regional And Country Analysis

  • 7.1. Global DNA And Gene Chip Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global DNA And Gene Chip Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific DNA And Gene Chip Market

  • 8.1. Asia-Pacific DNA And Gene Chip Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China DNA And Gene Chip Market

  • 9.1. China DNA And Gene Chip Market Overview
  • 9.2. China DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India DNA And Gene Chip Market

  • 10.1. India DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan DNA And Gene Chip Market

  • 11.1. Japan DNA And Gene Chip Market Overview
  • 11.2. Japan DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia DNA And Gene Chip Market

  • 12.1. Australia DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia DNA And Gene Chip Market

  • 13.1. Indonesia DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea DNA And Gene Chip Market

  • 14.1. South Korea DNA And Gene Chip Market Overview
  • 14.2. South Korea DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe DNA And Gene Chip Market

  • 15.1. Western Europe DNA And Gene Chip Market Overview
  • 15.2. Western Europe DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK DNA And Gene Chip Market

  • 16.1. UK DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany DNA And Gene Chip Market

  • 17.1. Germany DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France DNA And Gene Chip Market

  • 18.1. France DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy DNA And Gene Chip Market

  • 19.1. Italy DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain DNA And Gene Chip Market

  • 20.1. Spain DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe DNA And Gene Chip Market

  • 21.1. Eastern Europe DNA And Gene Chip Market Overview
  • 21.2. Eastern Europe DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia DNA And Gene Chip Market

  • 22.1. Russia DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America DNA And Gene Chip Market

  • 23.1. North America DNA And Gene Chip Market Overview
  • 23.2. North America DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA DNA And Gene Chip Market

  • 24.1. USA DNA And Gene Chip Market Overview
  • 24.2. USA DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada DNA And Gene Chip Market

  • 25.1. Canada DNA And Gene Chip Market Overview
  • 25.2. Canada DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America DNA And Gene Chip Market

  • 26.1. South America DNA And Gene Chip Market Overview
  • 26.2. South America DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil DNA And Gene Chip Market

  • 27.1. Brazil DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East DNA And Gene Chip Market

  • 28.1. Middle East DNA And Gene Chip Market Overview
  • 28.2. Middle East DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa DNA And Gene Chip Market

  • 29.1. Africa DNA And Gene Chip Market Overview
  • 29.2. Africa DNA And Gene Chip Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa DNA And Gene Chip Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa DNA And Gene Chip Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. DNA And Gene Chip Market Competitive Landscape And Company Profiles

  • 30.1. DNA And Gene Chip Market Competitive Landscape
  • 30.2. DNA And Gene Chip Market Company Profiles
    • 30.2.1. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Macrogen Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. DNA And Gene Chip Market Other Major And Innovative Companies

  • 31.1. Greiner Bio-One International GmbH
  • 31.2. CapitalBio Corporation
  • 31.3. Microarrays Inc.
  • 31.4. bioMerieux SA
  • 31.5. Applied Microarrays Inc.
  • 31.6. Biometrix Technology Inc.
  • 31.7. Oxford Gene Technology IP Limited
  • 31.8. Bioneer Corporation
  • 31.9. Eurofins MWG Operon LLC
  • 31.10. F. Hoffmann-La Roche Ltd
  • 31.11. QIAGEN N.V.
  • 31.12. Bio-Rad Laboratories Inc.
  • 31.13. BioChain Institute Inc.
  • 31.14. Cepheid
  • 31.15. Eppendorf AG

32. Global DNA And Gene Chip Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The DNA And Gene Chip Market

34. Recent Developments In The DNA And Gene Chip Market

35. DNA And Gene Chip Market High Potential Countries, Segments and Strategies

  • 35.1 DNA And Gene Chip Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 DNA And Gene Chip Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 DNA And Gene Chip Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer